CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Ceribell, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$26.00+0.96 (+3.83%)
Close on Oct 19, 2026
- Market cap
- $988.83M
- P/E (TTM)
- –
- Dividend yield
- –
Ceribell, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| Product revenue | $67.34M | $50.08M | $34.57M | 75.6% | +34.5% |
| Subscription revenue | $21.73M | $15.37M | $10.66M | 24.4% | +41.4% |
By region
From the segment and revenue-disaggregation notes of Ceribell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.